by Adam M. Brufsky, The Conversation Sugar is not only something that sweetens our food. It is also something that is an essential part of the proteins that make up our bodies. That led me to believe, as I wrote in the Journal of Medical Virology, that control of blood glucose by diet and exercise,...
by IDIBELL-Bellvitge Biomedical Research Institute Some solid tumors have a very high growth rate, which often leads to a lack of vascularization due to the impossibility to develop, at the same time, the blood vessels that accompany and nourish it. The team of Dr. Cristina Muñoz Pinedo, from the Bellvitge Biomedical Research Institute (IDIBELL) and...
By : Rich Haridy A newly published article in the New England Journal of Medicine is reporting the successful results of a clinical trial testing an experimental drug designed to treat psychosis in schizophrenia. The drug works unlike any other existing anti-psychotic medication, and without many of their negative side effects. The development of anti-psychotic...
Despite centuries-long efforts to develop cures for cancer, various forms of the disease will kill about 630,000 people in the U.S. in 2020. But hopes are rising for cell therapies – sometimes called “living medicines” – that can boost and adapt the natural cancer-fighting potential of the immune system in ways that conventional cancer treatments...
by Sanford Burnham Prebys Medical Discovery Institute Scientists at Sanford Burnham Prebys Medical Discovery Institute, the University of Hong Kong, Scripps Research, UC San Diego School of Medicine, the Icahn School of Medicine at Mount Sinai and UCLA have identified 30 existing drugs that stop the replication of SARS-CoV-2, the virus that causes COVID-19. Almost...
by Karen Finney, UC Davis UC Davis Health researchers have developed a computer model to screen drugs for unintended cardiac side effects, especially arrhythmia risk. Published in Circulation Research, the study was led by Colleen E. Clancy, professor of physiology and membrane biology, and Igor Vorobyov, assistant professor of physiology and membrane biology. Clancy is...
By: Kim Barker is an enterprise reporter BOSTON — On the first Monday in March, Michel Vounatsos, chief executive of the drug company Biogen, appeared in good spirits. The company’s new Alzheimer’s drug was showing promise after years of setbacks. Revenues had never been higher. Onstage at an elite health care conference in Boston, Mr....
Tori Marsh, MPH Tori Marsh, MPH, is on the Research team at GoodRx and is the resident expert on drug pricing and savings. Key takeaways: Hydroxychloroquine and chloroquine, which are both being tested as possible treatments for COVID-19, are officially experiencing shortages. Multiple other drugs that are essential in treating bacterial infections and placing patients...
Broad-spectrum antiviral agents could be a possible quick response to the potential COVID-19 pandemic NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY The number of people infected with the new corona virus continues to skyrocket, with more than 80000 cases worldwide as of the end of February. But there’s no vaccine or cure in sight, meaning that...
A clinical has begun trial testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will compare the safety, efficacy and cost-effectiveness of the two...
